Expression of arginase II in prostate cancer

International Journal of Oncology

Volumn 32, Issue 2, 2008, Pages 357-365

  Mumenthaler, Shannon M ^a   Yu, Hong ^a   Tze, Sheila ^a   Cederbaum, Stephen D ^a   Pegg, Anthony E ^b   Seligson, David B ^a   Grody, Wayne W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Arginase II; Ornithine aminotransferase; Polyamines; Prostate cancer; Tissue microarray

Indexed keywords

ARGINASE; ARGINASE II; ARGININE; ORNITHINE; ORNITHINE OXOACID AMINOTRANSFERASE; POLYAMINE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL STRAIN LNCAP; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DISEASE MARKER; GLEASON SCORE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; TISSUE MICROARRAY; WESTERN BLOTTING;

EID: 38849098350     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.2.357     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 206.
2. Bunting PS: Screening for prostate cancer with prostate-specific antigen: beware the biases. Clin Chim Acta 315: 71-97, 2002.
3. Tabib A and Bachrach U: Role of polyamines in mediating malignant transformation and oncogene expression. Int J Biochem Cell Biol 31: 1289-1295, 1999.
4. Calandra RS, Rulli SB, Frungieri MB, Suescun MO and Gonzalez-Calvar SI: Polyamines in the male reproductive system. Acta Physiol Pharmacol Ther Latinoam 46: 209-222, 1996.
5. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48: 759-774, 1988.
6. Russell DH: Polyamines and prostatic function. Prog Clin Biol Res 75A: 207-224, 1981.
7. Bettuzzi S, Davalli P, Astancolle S, Carani C, Madeo B, Tampieri A and Corti A: Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. Cancer Res 60: 28-34, 2000.
8. Seiler N, Atanassov CL and Raul F: Polyamine metabolism as target for cancer chemoprevention (Review). Int J Oncol 13: 993-1006, 1998.
9. Pegg AE, Shantz LM and Coleman CS: Omithine decarboxylase: structure, function and translational regulation. Biochem Soc Trans 22: 846-852, 1994.
10. Iyer R, Jenkinson CP, Vockley JG, Kern RM, Grody WW and Cederbaum S: The human arginases and arginase deficiency. J Inherit Metab Dis 21 (Suppl 1): 86-100, 1998.
11. Mezl VA and Knox WE: Metabolism of arginine in lactating rat mammary gland. Biochem J 166: 105-113, 1977.
12. Yoneda Y, Roberts E and Dietz GW Jr: A new synaptosomal biosynthetic pathway of glutamate and GABA from ornithine and its negative feedback inhibition by GABA. J Neurochem 38: 1686-1694, 1982.
13. Jenkinson CP, Grody WW and Cederbaum SD: Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 114: 107-132, 1996.
14. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P and Iyer RK: Arginases I and II: do their functions overlap? Mol Genet Metab 81 (Suppl 1): 38-44, 2004.
15. Marton LJ and Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35: 55-91, 1995.
16. Mohan RR, Challa A, Gupta S, Bostwick DG, Ahmad N, Agarwal R, Marengo SR, Amini SB, Paras F, MacLennan GT, Resnick MI and Mukhtar H: Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. Clin Cancer Res 5: 143-147, 1999.
17. Vockley JG, Jenkinson CP, Shulda H, Kern RM, Grody WW and Cederbaum SD: Cloning and characterization of the human type II arginase gene. Genomics 38: 118-123, 1996.
18. Chang CI, Liao JC and Kuo L: Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61: 1100-1106, 2001.
19. Elgun S, Keskinege A, Yilmaz E, Baltaci S and Beduk Y: Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer. Int Urol Nephrol 31: 95-99, 1999.
20. Singh R, Pervin S, Karimi A, Cederbaum S and Chaudhuri G: Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res 60: 3305-3312, 2000.
21. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847, 1998.
22. Freedland SJ, Seligson DB, Liu AY, Pantuck AJ, Paik SH, Horvath S, Wieder JA, Zisman A, Nguyen D, Tso CL, Palotie AV and Belldegrun AS: Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate 55: 71-80, 2003.
23. Pegg AE, Wechter R, Pakala R amd Bergeron RJ: Effect of N1, N12-bis(ethyl)spermine and related compounds on growth and polyamine acetylation, content, and excretion in human colon tumor cells. J Biol Chem 264: 11744-11749, 1989.
24. Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A, Shi T, Liu X, Chia D, Goodglick L and Bonavida B: Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol 27: 131-141, 2005.
25. Humphrey PA: Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol 17: 292-306, 2004.
26. Han KR, Seligson DB, Liu X, Horvath S, Shintaku PI, Thomas GV, Said JW and Reiter RE: Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. J Urol 171: 1117-1121, 2004.
27. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1983.
28. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL, Nordeen SK, Miller GJ and Lucia MS: Molecular characterization of human prostate carcinoma cell lines. Prostate 57: 205-225, 2003.
29. Bronte V, Kasic T, Gri G, Gallana K, Borsellino G, Marigo I, Battistini L, Iafrate M, Prayer-Galetti T, Pagano F and Viola A: Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J Exp Med 201: 1257-1268, 2005.
30. Harris BE, Pretlow TP, Bradley EL Jr, Whitehurst GB and Pretlow TG II: Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. Cancer Res 43: 3008-3012, 1983.
31. Keskinege A, Elgun S and Yilmaz E: Possible implications of arginase and diamine oxidase in prostatic carcinoma. Cancer Detect Prev 25: 76-79, 2001.
32. Yamanaka H, Mayuzumi T, Matsuoka M, Shimazaki J and Shida K: Arginase in human urogenital tumors. GANN 63: 693-700, 1972.
33. Mendez JD, Sosa A and Palomar-Morales M: Effect of L-arginine on arginase activity in male accessory sex glands of alloxantreated rats. Reprod Toxicol 16: 809-813, 2002.
34. Yamanaka H, Kirdani RY, Saroff J, Murphy GP and Sandberg AA: Effects of testosterone and prolactin on rat prostatic weight, 5alpha-reductase, and arginase. Am J Physiol 229: 1102-1109, 1975.
35. Manteuffel-Cymborowska M, Chmurzynska W, Peska M and Grzelakowska-Sztabert B: Arginine and ornithine metabolizing enzymes in testosterone-induced hypertrophic mouse kidney. Int J Biochem Cell Biol 27: 287-295, 1995.
36. Levillain O, Diaz JJ, Blanchard O and Dechaud H: Testosterone down-regulates ornithine aminotransferase gene and up-regulates arginase II and ornithine decarboxylase genes for polyamines synthesis in the murine kidney. Endocrinology 146: 950-959, 2005.
37. Rui H, Brekke I, Morkas L and Purvis K: Androgen interaction with the polyamine system of the rat prostate. Andrologia 19: 134-142, 1987.
38. Pretlow TG II, Harris BE, Bradley EL Jr, Bueschen AJ, Lloyd KL and Pretlow TP: Enzyme activities in prostatic carcinoma related to Gleason grades. Cancer Res 45: 442-446, 1985.
39. Holtta E and Pohjanpelto P: Polyamine dependence of Chinese hamster ovary cells in serum-free culture is due to deficient arginase activity. Biochim Biophys Acta 721: 321-327, 1982.
40. Oka T and Perry JW: Arginase affects lactogenesis through its influence on the biosynthesis of spermidine. Nature 250: 660-661, 1974.
41. Pegg AE and McCann PP: Polyamine metabolism and function. Am J Physiol 243: C212-C221, 1982.
42. Schipper RG, Romijn JC, Cuijpers VM and Verhofstad AA: Polyamines and prostatic cancer. Biochem Soc Trans 31: 375-380, 2003.
43. Peraino C, Bunville LG and Tahmisian TN: Chemical, physical, and morphological properties of ornithine aminotransferase from rat liver. J Biol Chem 244: 2241-2249, 1969.
44. Wang T, Lawler AM, Steel G, Sipila I, Milam AH and Valle D: Mice lacking ornithine-delta-aminotransferase have paradoxical neonatal hypoornithinaemia and retinal degeneration. Nat Genet 11: 185-190, 1995.
45. Mitchell GA, Looney JE, Brody LC, Steel G, Suchanek M, Engelhardt JF, Willard HF and Valle D: Human ornithine-delta-aminotransferase, cDNA cloning and analysis of the structural gene. J Biol Chem 263: 14288-14295, 1988.
46. Zintz CB and Inana G: Analysis of the human ornithine aminotransferase gene family. Exp Eye Res 50: 759-770, 1990.
47. Hayashi T, Matsufuji S and Hayashi S: Characterization of the human antizyme gene. Gene 203: 131-139, 1997.
48. Kramer DL, Sufrin JR and Porter CW: Modulation of polyaminebiosynthetic activity by S-adenosylmethionine depletion. Biochem J 249: 581-586, 1988.